Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice - Wikidata - wikimedia - TriplyDB

Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice

Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice

http://www.wikidata.org/entity/Q37624843

about

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling.Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus.TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice Conophylline inhibits non-alcoholic steatohepatitis in mice Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice.A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis HCC development is associated to peripheral insulin resistance in a mouse model of NASH.Potent natural products and herbal medicines for treating liver fibrosis Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.A Cell-type-resolved Liver Proteome.The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.TAK1 regulates hepatic cell survival and carcinogenesis.Advanced oxidation protein products induce hepatocyte epithelial-mesenchymal transition via a ROS-dependent, TGF-β/Smad signaling pathway.Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/- mice.Ethanol Enhances TGF-β Activity by Recruiting TGF-β Receptors From Intracellular Vesicles/Lipid Rafts/Caveolae to Non-Lipid Raft Microdomains.miRNAs in non-alcoholic fatty liver disease.The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice.Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.Transforming growth factor-β signaling pathway-associated genes SMAD2 and TGFBR2 are implicated in metabolic syndrome in a Taiwanese population.Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways.Reply: To PMID 23996730.Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish.MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin.Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis.Fatty acid synthase is required for profibrotic TGF-β signaling.To die or not to die: death signaling in nonalcoholic fatty liver disease.Apoptosis and non-alcoholic fatty liver diseases.Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis

P2860

Q27006992-9D73FD6A-29BA-4D5C-AC56-7C4C57DED966 Q28079713-B991EBD8-2B1F-43D7-B400-9B52DC7003DE Q28080239-81B32D89-7D5E-4442-BC6E-1A1A3067EF56 Q30359251-3DC17DFF-C9D5-4E7E-A79C-F90A1E6DBD74 Q33686468-FD936CDC-575B-4E09-954A-4F46BBD076CA Q33774406-AD584A7F-3850-428B-9BF1-007ED6058E69 Q33778383-FEC708D2-227A-4450-AE34-59B62909CAFC Q33802693-2C8B9B76-FE74-4A40-A556-A1DCC07869A6 Q33863032-132400BA-8A89-4F2C-85E8-DDCCCCEAF7C1 Q34131187-53756239-3726-4993-B8E6-C73679993394 Q35086412-9172D951-1739-4F8E-96CD-C97A2FF53159 Q35172679-E60DF408-E8A4-442C-AE76-91AC11323C1B Q35494410-DC14C4EF-0699-4711-A552-9E47A54E7272 Q36195780-9E475EF0-915C-4A92-B9A7-F916A7BC54AD Q36367829-719723B7-DAB8-4C96-87E1-600B3729C4B3 Q36673866-52B3D257-1892-4409-BC25-C18ADB8BA2B4 Q37318955-04AC7C39-D83A-43D8-B35C-8E9B239ECB33 Q37566373-E27CD3ED-88EB-4D6C-A8CF-34F43BA0CA46 Q38180064-9B3B7837-9F15-4712-A07F-1D5F88D7183C Q38703623-A8F07AE6-5486-460E-9884-0D5830ECC1BB Q38719582-5806AEFC-E880-481F-BB41-E81E4B3974C6 Q38730296-A47CD447-5F60-4582-B6D1-F23FA258E98A Q38831496-4AC19200-5FA9-4E49-B473-EB6390DEB02F Q38966905-7F9C6155-3937-4D8B-ADCC-2A606323FAA1 Q39499177-051FC292-038D-48B1-85CD-8812A647640D Q40154406-299CEAB0-AEAB-4231-B926-459097B2808A Q42670499-9366D418-92F9-4CD2-8869-9BFB63871F2C Q42705478-2B66D001-C340-40AF-B9EA-989E1C76E6E7 Q43146482-2B26FADF-B1E7-4EA6-B0A8-1FB4E75D652B Q44587681-DB8233E1-0184-4B26-BD18-A37E0E212F86 Q44765599-E538F5CE-E298-4458-8618-F12FA60C0DF5 Q46503559-16F29394-7F84-4C42-846B-F80E489DDE7E Q47105075-723A3AEE-DCC7-4B6F-9163-13FE7484C514 Q47589822-38C560C0-4ADF-480D-A17D-C5BA2FD77658 Q47642289-47E944FE-DF7A-4C23-AE81-CB1F6C9C0138 Q49910295-49ED43F2-1A81-49DB-A32E-24C0AAB3AB4E Q52373813-1574B0A9-1850-4D59-BDD8-A0116E8D5579 Q54119547-5314E389-FD76-472C-83BD-1AC82A8C088E Q55503094-13A22FDC-EBD6-451D-8161-44DF5DA073A7 Q57794656-8E3DBB4E-03A2-4CCC-92B2-8F320F552207

P2860

Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice

http://www.wikidata.org/entity/Q37624843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Transforming growth factor bet ...... h and lipid metabolism in mice

@en

Transforming growth factor bet ...... and lipid metabolism in mice.

@nl

type

label

Transforming growth factor bet ...... h and lipid metabolism in mice

@en

Transforming growth factor bet ...... and lipid metabolism in mice.

@nl

prefLabel

Transforming growth factor bet ...... h and lipid metabolism in mice

@en

Transforming growth factor bet ...... and lipid metabolism in mice.

@nl

P1433

Q37624843-7956B965-1590-47CC-9B80-A06DDF9678E5

P1476

Q37624843-DA8EC331-BCA3-4353-9D1E-345FB4EEA0F9

P2093

Q37624843-1429D75E-405C-4BBB-B374-1B260D1921A4

Q37624843-3064798E-C6F9-4900-81FA-DB8A9BE314D0

Q37624843-43039722-F53C-401C-AC21-6CA8294D03EC

Q37624843-616CFEE5-BE6D-46A7-92F5-1F7CF8D83BE7

Q37624843-84399F88-4B34-422E-BE0A-09D1F6D20C21

Q37624843-B89C8EB6-F3F5-442B-9EE6-BAA7FBB56637

Q37624843-F8CE0DDA-3C50-4ACF-9DB4-6DA72CE1880E

P2860

Q37624843-038727F1-6C4F-40A9-B530-60E90A748CEA

Q37624843-078A98E9-2FE0-4BB8-B79C-A083111DE836

Q37624843-0B78DDC9-CC15-44D6-8D4C-807D9BB1F425

Q37624843-0D4B296F-1DD6-441C-A0E9-7A29A532B60D

Q37624843-1361964E-309A-4004-B786-7EC2A217AFBC

Q37624843-1BB311CE-6D51-4E2B-B485-2FB3F95FDC4B

Q37624843-2A050C07-1FD8-4F37-B18B-85748E19D724

Q37624843-2A33821D-BA2B-47E7-BE0F-10E5F96F8522

Q37624843-30D247E7-C8F2-44FA-B5D5-13C86DACCEF7

Q37624843-32FABBFA-83EA-417F-9F46-2593198C5546

P304

Q37624843-34C6404A-961E-4734-8768-C92AEF48707E

P31

Q37624843-A8CEF596-6A18-4430-8633-42294CC6666D

P356

Q37624843-3403E2A1-BFB5-4CBA-8E81-51A5949FE523

P407

Q37624843-B11856E8-BE1B-4E94-B473-32D7625EB6BB

P433

Q37624843-52A47FC0-5228-4E17-BB34-D0EC2B7F635E

P478

Q37624843-04452583-BA27-4530-9C83-E23037C0FD58

P577

Q37624843-801E9876-CF78-4154-BBDD-D5CBA23668B3

P698

Q37624843-FDE9B171-AFF5-4E0A-8226-BD553648368E

P921

Q37624843-051C82F7-271D-42F5-AB67-7C93ED86C1B0

P932

Q37624843-C11A6195-5170-4AD7-98D7-AD8206699D52

P356

P1433

P1476

Transforming growth factor bet ...... h and lipid metabolism in mice

@en

P2093

Bi Zhang

http://www.w3.org/2001/XMLSchema#string

Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Ekihiro Seki

http://www.w3.org/2001/XMLSchema#string

Jingyi Song

http://www.w3.org/2001/XMLSchema#string

Ling Yang

http://www.w3.org/2001/XMLSchema#string

Rohit Loomba

http://www.w3.org/2001/XMLSchema#string

Yoon Seok Roh

http://www.w3.org/2001/XMLSchema#string

P2860

Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Metabolic endotoxemia initiates obesity and insulin resistance

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

TLR4 enhances TGF-beta signaling and hepatic fibrosis

Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Roles of TGF-beta in hepatic fibrosis.

Inflammatory links between obesity and metabolic disease.

A key role for NOX4 in epithelial cell death during development of lung fibrosis.

P304

483-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26698

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23996730

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3946696

http://www.w3.org/2001/XMLSchema#string